Progyny, Inc. (NASDAQ:PGNY) Shares Sold by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS reduced its position in shares of Progyny, Inc. (NASDAQ:PGNYFree Report) by 5.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,816 shares of the company’s stock after selling 972 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Progyny were worth $273,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Intech Investment Management LLC raised its stake in shares of Progyny by 282.0% during the 3rd quarter. Intech Investment Management LLC now owns 42,013 shares of the company’s stock worth $704,000 after buying an additional 31,014 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in Progyny by 0.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 673,446 shares of the company’s stock worth $11,287,000 after acquiring an additional 4,007 shares in the last quarter. Quantbot Technologies LP acquired a new stake in Progyny in the third quarter valued at $2,187,000. Public Sector Pension Investment Board purchased a new stake in shares of Progyny during the 3rd quarter worth $2,792,000. Finally, Edgestream Partners L.P. grew its stake in shares of Progyny by 72.7% during the 3rd quarter. Edgestream Partners L.P. now owns 69,082 shares of the company’s stock worth $1,158,000 after purchasing an additional 29,074 shares during the period. Institutional investors and hedge funds own 94.93% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on PGNY shares. JPMorgan Chase & Co. raised their price objective on shares of Progyny from $17.00 to $23.00 and gave the company a “neutral” rating in a research note on Tuesday, January 28th. Bank of America lifted their price target on shares of Progyny from $21.00 to $25.00 and gave the company a “buy” rating in a research report on Tuesday, February 11th. Finally, Canaccord Genuity Group boosted their price target on Progyny from $17.00 to $23.00 and gave the stock a “hold” rating in a research note on Friday, February 28th. Nine analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, Progyny currently has a consensus rating of “Hold” and a consensus price target of $24.82.

Read Our Latest Analysis on PGNY

Progyny Stock Up 2.2 %

PGNY opened at $22.31 on Friday. The firm has a market cap of $1.91 billion, a P/E ratio of 38.47, a PEG ratio of 2.39 and a beta of 1.41. The business’s fifty day simple moving average is $22.05 and its 200 day simple moving average is $18.58. Progyny, Inc. has a 52 week low of $13.39 and a 52 week high of $38.98.

Progyny Company Profile

(Free Report)

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

Further Reading

Want to see what other hedge funds are holding PGNY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Progyny, Inc. (NASDAQ:PGNYFree Report).

Institutional Ownership by Quarter for Progyny (NASDAQ:PGNY)

Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.